BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Neutral
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Price: $13.30 -0.45%
Rating Summary:
8 Buy, 2 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
8 Buy, 2 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Dr. Reddy's Laboratories (NYSE: RDY) from Buy to Neutral following Q3 results.
For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here.
Shares of Dr. Reddy's Laboratories closed at $34.82 yesterday.
For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here.
Shares of Dr. Reddy's Laboratories closed at $34.82 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Resumes Williams-Sonoma (WSM) at Buy
- Stifel Downgrades DCC Plc. (DCC:LN) (DCCPF) to Hold
- BofA Securities Starts Avalo Therapeutics Inc. (AVTX) at Buy
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
